Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma

Background: Increasing evidence has shown that tumor initiation and growth are nourished by a small subpopulation of cancer stem cells (CSCs) within the tumor mass. CSCs are posited to be responsible for tumor maintenance, growth, distant metastasis, and relapse after curative operation. We examined...

Full description

Bibliographic Details
Main Authors: Jong Jin Sung, Sang Jae Noh, Jun Sang Bae, Ho Sung Park, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2016-01-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2015-10-09.pdf
_version_ 1818965024827244544
author Jong Jin Sung
Sang Jae Noh
Jun Sang Bae
Ho Sung Park
Kyu Yun Jang
Myoung Ja Chung
Woo Sung Moon
author_facet Jong Jin Sung
Sang Jae Noh
Jun Sang Bae
Ho Sung Park
Kyu Yun Jang
Myoung Ja Chung
Woo Sung Moon
author_sort Jong Jin Sung
collection DOAJ
description Background: Increasing evidence has shown that tumor initiation and growth are nourished by a small subpopulation of cancer stem cells (CSCs) within the tumor mass. CSCs are posited to be responsible for tumor maintenance, growth, distant metastasis, and relapse after curative operation. We examined the expression of CSC markers in paraffin-embedded tissue sections of hepatocellular carcinoma (HCC) and correlated the results with clinicopathologic characteristics. Methods: Immunohistochemical staining for the markers believed to be expressed in the CSCs, including epithelial cell adhesion molecule (EpCAM), keratin 19 (K19), CD133, and CD56, was performed in 82 HCC specimens. Results: EpCAM expression was observed in 56% of the HCCs (46/82) and K19 in 6% (5/82). EpCAM expression in HCC significantly correlated with elevated α-fetoprotein level, microvessel invasion of tumor cells, and high histologic grade. In addition, EpCAM expression significantly correlated with K19 expression. The overall survival and relapsefree survival rates in patients with EpCAM-expressing HCC were relatively lower than those in patients with EpCAM-negative HCC. All but two of the 82 HCCs were negative for CD133 and CD56, respectively. Conclusions: Our results suggest that HCCs expressing EpCAM are associated with unfavorable prognostic factors and have a more aggressive clinical course than those not expressing EpCAM. Further, the expression of either CD133 or CD56 in paraffin-embedded HCC tissues appears to be rare.
first_indexed 2024-12-20T13:10:26Z
format Article
id doaj.art-ed5efcaef2ab44c494dc09befe0ad1e9
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-12-20T13:10:26Z
publishDate 2016-01-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-ed5efcaef2ab44c494dc09befe0ad1e92022-12-21T19:39:41ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452016-01-01501525710.4132/jptm.2015.10.0916575Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular CarcinomaJong Jin SungSang Jae NohJun Sang BaeHo Sung ParkKyu Yun JangMyoung Ja ChungWoo Sung MoonBackground: Increasing evidence has shown that tumor initiation and growth are nourished by a small subpopulation of cancer stem cells (CSCs) within the tumor mass. CSCs are posited to be responsible for tumor maintenance, growth, distant metastasis, and relapse after curative operation. We examined the expression of CSC markers in paraffin-embedded tissue sections of hepatocellular carcinoma (HCC) and correlated the results with clinicopathologic characteristics. Methods: Immunohistochemical staining for the markers believed to be expressed in the CSCs, including epithelial cell adhesion molecule (EpCAM), keratin 19 (K19), CD133, and CD56, was performed in 82 HCC specimens. Results: EpCAM expression was observed in 56% of the HCCs (46/82) and K19 in 6% (5/82). EpCAM expression in HCC significantly correlated with elevated α-fetoprotein level, microvessel invasion of tumor cells, and high histologic grade. In addition, EpCAM expression significantly correlated with K19 expression. The overall survival and relapsefree survival rates in patients with EpCAM-expressing HCC were relatively lower than those in patients with EpCAM-negative HCC. All but two of the 82 HCCs were negative for CD133 and CD56, respectively. Conclusions: Our results suggest that HCCs expressing EpCAM are associated with unfavorable prognostic factors and have a more aggressive clinical course than those not expressing EpCAM. Further, the expression of either CD133 or CD56 in paraffin-embedded HCC tissues appears to be rare.http://www.jpatholtm.org/upload/pdf/jptm-2015-10-09.pdfCarcinoma, hepatocellularEpCAM proteinCancer stem cells
spellingShingle Jong Jin Sung
Sang Jae Noh
Jun Sang Bae
Ho Sung Park
Kyu Yun Jang
Myoung Ja Chung
Woo Sung Moon
Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
Journal of Pathology and Translational Medicine
Carcinoma, hepatocellular
EpCAM protein
Cancer stem cells
title Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
title_full Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
title_fullStr Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
title_full_unstemmed Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
title_short Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
title_sort immunohistochemical expression and clinical significance of suggested stem cell markers in hepatocellular carcinoma
topic Carcinoma, hepatocellular
EpCAM protein
Cancer stem cells
url http://www.jpatholtm.org/upload/pdf/jptm-2015-10-09.pdf
work_keys_str_mv AT jongjinsung immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT sangjaenoh immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT junsangbae immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT hosungpark immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT kyuyunjang immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT myoungjachung immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma
AT woosungmoon immunohistochemicalexpressionandclinicalsignificanceofsuggestedstemcellmarkersinhepatocellularcarcinoma